Dias S S, Milne D M, Meek D W
Molecular Signalling Group, Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
Oncogene. 2006 Oct 26;25(50):6666-71. doi: 10.1038/sj.onc.1209671. Epub 2006 May 15.
The p53 tumour-suppressor protein is tightly regulated through its association with the Hdm2 E3 ligase. Activation of p53 by DNA strand breaks is orchestrated by the ataxia-telangiectasia mutated (ATM) protein kinase and involves interruption of Hdm2-mediated p53 degradation. As part of this mechanism ATM itself, and the ATM-activated protein tyrosine kinase, c-Abl, inhibit Hdm2 function through phosphorylation of serine 395 and tyrosine 394 (Y394), respectively. In the present study, we have identified a novel target of c-Abl in the Hdm2 protein, tyrosine 276 (Y276). We show that c-Abl phosphorylates this residue in vitro and confirm that Y394 is a target of c-Abl. We also show that Y276 is phosphorylated in a c-Abl-dependent manner in cultured cells and provide evidence that Y276 is phosphorylated in response to DNA damage coincident with the activation of c-Abl. Finally, we show that Y276 phosphorylation stimulates interaction with ARF, leading to increased levels of nucleolar Hdm2 and decreased turnover of p53. These data establish Y276 as a physiological target of c-Abl that contributes functionally to the induction of p53.
p53肿瘤抑制蛋白通过与Hdm2 E3连接酶的结合受到严格调控。DNA链断裂对p53的激活由共济失调毛细血管扩张症突变(ATM)蛋白激酶精心调控,且涉及Hdm2介导的p53降解的中断。作为该机制的一部分,ATM自身以及ATM激活的蛋白酪氨酸激酶c - Abl分别通过磷酸化丝氨酸395和酪氨酸394(Y394)来抑制Hdm2功能。在本研究中,我们在Hdm2蛋白中鉴定出了c - Abl的一个新靶点,酪氨酸276(Y276)。我们证明c - Abl在体外使该残基磷酸化,并证实Y394是c - Abl的一个靶点。我们还表明Y276在培养细胞中以c - Abl依赖的方式被磷酸化,并提供证据表明Y276在响应DNA损伤时与c - Abl的激活同时被磷酸化。最后,我们表明Y276磷酸化刺激与ARF的相互作用,导致核仁Hdm2水平升高和p53周转减少。这些数据确立Y276为c - Abl的一个生理靶点,其在功能上有助于p53的诱导。